GILD

Gilead Sciences (GILD) Shows High Options Volume

Put options volume in Gilead Sciences (GILD) saw a huge jump on Friday--could the bearish sentiment continue? More

Take the Money and Run in This Biotech

Following two FDA rejections and two sell signals, it's time to cash out of Gilead Sciences. More

Bulls vs. Bears: Can Biogen Keep Booming?

Biogen has been soaring on news of its recent drug approval, but the question remains when it can keep it up. Here are the bullish and bearish arguments. More

Buy These 3 S&P 500 Stocks Now

These blue-chips are the best of the best -- and the upside could be huge. More

An HIV ‘Cure’? Let’s Not Overstate the Success

Merck, J&J and others won't be dropping their research to recreate the success seen in the early treatment of an HIV-positive child. More

5 Biotechnology Stocks to Buy Now

This week, five Biotechnology stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More